Rare peripheral precocious puberty

Rare peripheral precocious puberty, also known as gonadotropin-independent precocious puberty or pseudo-precocious puberty, is a group of uncommon conditions in which signs of puberty develop earlier than expected due to excess sex hormone production from sources other than the normal hypothalamic-pituitary-gonadal axis. Unlike central precocious puberty, which is driven by premature activation of the brain's gonadotropin-releasing hormone (GnRH) pulse generator, peripheral precocious puberty arises from autonomous sex steroid secretion by the gonads, adrenal glands, or other tissues, or from exogenous hormone exposure. This category encompasses several rare etiologies including McCune-Albright syndrome, familial male-limited precocious puberty (testotoxicosis), congenital adrenal hyperplasia variants, sex hormone-secreting tumors (ovarian, testicular, adrenal, or ectopic hCG-secreting tumors), and severe primary hypothyroidism (Van Wyk-Grumbach syndrome). Clinical features depend on the underlying cause and the sex of the affected child but generally include premature development of secondary sexual characteristics such as breast development or testicular enlargement, pubic and axillary hair growth, accelerated linear growth, and advanced bone age. In girls, vaginal bleeding or ovarian cysts may occur; in boys, asymmetric testicular enlargement may suggest a tumor. If untreated, the accelerated skeletal maturation can lead to early epiphyseal fusion and compromised adult height. Affected children may also experience psychosocial difficulties related to their early physical maturation. Treatment is directed at the underlying cause and differs significantly from central precocious puberty management. GnRH agonists, which are the standard treatment for central precocious puberty, are ineffective in peripheral forms because the hormone production is independent of pituitary gonadotropins. Instead, therapeutic approaches may include surgical removal of hormone-secreting tumors, aromatase inhibitors (such as letrozole or anastrozole), anti-androgens (such as spironolactone or bicalutamide), ketoconazole to inhibit steroidogenesis, or tamoxifen. In McCune-Albright syndrome and testotoxicosis, combination medical therapy is often employed. Glucocorticoid replacement is the mainstay for congenital adrenal hyperplasia. Regular monitoring of growth velocity, bone age, and hormonal levels is essential to guide treatment and optimize outcomes.

Common questions about Rare peripheral precocious puberty